{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:29Z","timestamp":1786981289303,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T00:00:00Z","timestamp":1307232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10875-011-9548-0","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T19:29:20Z","timestamp":1307129360000},"page":"737-743","source":"Crossref","is-referenced-by-count":12,"title":["The Relationship Between Hypogammaglobulinemia, Monoclonal Gammopathy of Undetermined Significance and Humoral Immunodeficiency: a Case Series"],"prefix":"10.1007","volume":"31","author":[{"given":"Robert Marc","family":"Zemble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Takach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold I.","family":"Levinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,5]]},"reference":[{"key":"9548_CR1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978;64:814\u201326.","journal-title":"Am J Med"},{"key":"9548_CR2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362\u20139.","journal-title":"N Engl J Med"},{"key":"9548_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564\u20139.","journal-title":"N Engl J Med"},{"key":"9548_CR4","doi-asserted-by":"crossref","unstructured":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003; 121: 749\u2013757.","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"9548_CR5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121\u20137.","journal-title":"Leukemia"},{"key":"9548_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb01584.x","volume":"48","author":"F Aguzzi","year":"1992","unstructured":"Aguzzi F, Bergami MR, Gasparro C, Bellotti V, Merlini G. Occurrence of monoclonal components in general practice: clinical implications. Eur J Haematol. 1992;48:192\u20135.","journal-title":"Eur J Haematol"},{"key":"9548_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","volume":"179","author":"U Axelsson","year":"1966","unstructured":"Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. Acta Med Scand. 1966;179:235\u201347.","journal-title":"Acta Med Scand"},{"key":"9548_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1445-5994.1971.tb02551.x","volume":"1","author":"RW Carrell","year":"1971","unstructured":"Carrell RW, Colls BM, Murray JT. The significance of monoclonal gammopathy in a normal population. Aust N Z J Med. 1971;1:398\u2013401.","journal-title":"Aust N Z J Med"},{"key":"9548_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","volume":"104","author":"HJ Cohen","year":"1998","unstructured":"Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med. 1998;104:439\u201344.","journal-title":"Am J Med"},{"key":"9548_CR10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0954-6820.1963.tb17460.x","volume":"173","author":"J Hallen","year":"1963","unstructured":"Hallen J. Frequency of \"abnormal\" serum globulins (M-components) in the aged. Acta Med Scand. 1963;173:737\u201344.","journal-title":"Acta Med Scand"},{"key":"9548_CR11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","volume":"40","author":"RA Kyle","year":"1972","unstructured":"Kyle RA, Finkelstein S, Elveback LR, Kurland LT. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood. 1972;40:719\u201324.","journal-title":"Blood"},{"key":"9548_CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jcp.40.7.793","volume":"40","author":"V Malacrida","year":"1987","unstructured":"Malacrida V, De Francesco D, Banfi G, Porta FA, Riches PG. Laboratory investigation of monoclonal gammopathy during 10\u00a0years of screening in a general hospital. J Clin Pathol. 1987;40:793\u20137.","journal-title":"J Clin Pathol"},{"key":"9548_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF. Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol. 1982;35:63\u20138.","journal-title":"J Clin Pathol"},{"key":"9548_CR14","first-page":"157","volume":"17","author":"AO Vladutiu","year":"1987","unstructured":"Vladutiu AO. Prevalence of M-proteins in serum of hospitalized patients. Physicians\u2019 response to finding M-proteins in serum protein electrophoresis. Ann Clin Lab Sci. 1987;17:157\u201361.","journal-title":"Ann Clin Lab Sci"},{"key":"9548_CR15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","volume":"87","author":"L Baldini","year":"1996","unstructured":"Baldini L, Guffanti A, Cesana BM, Colombi M, Chiorboli O, Damilano I, et al. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood. 1996;87:912\u20138.","journal-title":"Blood"},{"key":"9548_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","volume":"81","author":"J Blade","year":"1992","unstructured":"Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, et al. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol. 1992;81:391\u20134.","journal-title":"Br J Haematol"},{"key":"9548_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1980.tb06013.x","volume":"46","author":"A Carter","year":"1980","unstructured":"Carter A, Tatarsky I. The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases. Br J Haematol. 1980;46:565\u201374.","journal-title":"Br J Haematol"},{"key":"9548_CR18","first-page":"1172","volume":"86","author":"H Gregersen","year":"2001","unstructured":"Gregersen H, Mellemkjaer L, Ibsen JS, Dahlerup JF, Thomassen L, Sorensen HT. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Haematologica. 2001;86:1172\u20139.","journal-title":"Haematologica"},{"key":"9548_CR19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2141.1997.1072923.x","volume":"97","author":"J Vuckovic","year":"1997","unstructured":"Vuckovic J, Ilic A, Knezevic N, Marinkovic M, Zemunik T, Dubravcic M. Prognosis in monoclonal gammopathy of undetermined significance. Br J Haematol. 1997;97:649\u201351.","journal-title":"Br J Haematol"},{"key":"9548_CR20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","volume":"20","author":"C Cesana","year":"2002","unstructured":"Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, et al. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol. 2002;20:1625\u201334.","journal-title":"J Clin Oncol"},{"key":"9548_CR21","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","volume":"111","author":"LM Brown","year":"2008","unstructured":"Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111:3388\u201394.","journal-title":"Blood"},{"key":"9548_CR22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immun. 2005;94:S1\u2013S63.","journal-title":"Ann Allergy Asthma Immun"},{"key":"9548_CR23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","volume":"99","author":"K Paris","year":"2007","unstructured":"Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immun. 2007;99:462\u20134.","journal-title":"Ann Allergy Asthma Immun"},{"key":"9548_CR24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","volume":"372","author":"MA Park","year":"2008","unstructured":"Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372:489\u2013502.","journal-title":"Lancet"},{"key":"9548_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02785839","volume":"16","author":"MC Kyrtsonis","year":"1999","unstructured":"Kyrtsonis MC, Mouzaki A, Maniatis A. Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM). Med Oncol. 1999;16:73\u20137.","journal-title":"Med Oncol"},{"key":"9548_CR26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJM197510302931801","volume":"293","author":"S Broder","year":"1975","unstructured":"Broder S, Humphrey R, Durm M, Blackman M, Meade B, Goldman C, et al. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma: role of suppressor cells. N Engl J Med. 1975;293:887\u201392.","journal-title":"N Engl J Med"},{"key":"9548_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.2830300208","volume":"30","author":"M Kawano","year":"1989","unstructured":"Kawano M, Iwato K, Asaoku H, Tanabe O, Tanaka H, Ishikawa H, et al. Altered cytokine activities are related to the suppression of synthesis of normal immunoglobulin in multiple myeloma. Am J Hematol. 1989;30:91\u20136.","journal-title":"Am J Hematol"},{"key":"9548_CR28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4049\/jimmunol.124.1.268","volume":"124","author":"J Kennard","year":"1980","unstructured":"Kennard J, Zolla-Pazner S. Origin and function of suppressor macrophages in myeloma. J Immunol. 1980;124:268\u201373.","journal-title":"J Immunol"},{"key":"9548_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02989591","volume":"15","author":"MC Kyrtsonis","year":"1998","unstructured":"Kyrtsonis MC, Repa C, Dedoussis GV, Mouzaki A, Simeonidis A, Stamatelou M, et al. Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma. Med Oncol. 1998;15:124\u20138.","journal-title":"Med Oncol"},{"key":"9548_CR30","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood.V85.12.3679.bloodjournal85123679","volume":"85","author":"M Massaia","year":"1995","unstructured":"Massaia M, Borrione P, Attisano C, Barral P, Beggiato E, Montacchini L, et al. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood. 1995;85:3679\u201387.","journal-title":"Blood"},{"key":"9548_CR31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00525.x","volume":"100","author":"AC Rawstron","year":"1998","unstructured":"Rawstron AC, Davies FE, Owen RG, English A, Pratt G, Child JA, et al. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors. Br J Haematol. 1998;100:176\u201383.","journal-title":"Br J Haematol"},{"key":"9548_CR32","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1182\/blood.V87.8.3375.bloodjournal8783375","volume":"87","author":"T Tsujimoto","year":"1996","unstructured":"Tsujimoto T, Lisukov IA, Huang N, Mahmoud MS, Kawano MM. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells. Blood. 1996;87:3375\u201383.","journal-title":"Blood"},{"key":"9548_CR33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34\u201348.","journal-title":"Clin Immunol"},{"key":"9548_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","volume":"130","author":"L Mellemkjaer","year":"2002","unstructured":"Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130:495\u2013500.","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-011-9548-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9548-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T02:13:43Z","timestamp":1686104023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-011-9548-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9548"],"URL":"https:\/\/doi.org\/10.1007\/s10875-011-9548-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,5]]}}}